Junfeng Xu

733 total citations
30 papers, 563 citations indexed

About

Junfeng Xu is a scholar working on Molecular Biology, Cancer Research and Physiology. According to data from OpenAlex, Junfeng Xu has authored 30 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Cancer Research and 7 papers in Physiology. Recurrent topics in Junfeng Xu's work include Cancer-related molecular mechanisms research (7 papers), Epigenetics and DNA Methylation (6 papers) and Telomeres, Telomerase, and Senescence (5 papers). Junfeng Xu is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), Epigenetics and DNA Methylation (6 papers) and Telomeres, Telomerase, and Senescence (5 papers). Junfeng Xu collaborates with scholars based in China, United States and Taiwan. Junfeng Xu's co-authors include Jun Hu, Li Guo, Zhijian Sun, Yuxiong Feng, Dong Xie, Jiang‐Sha Zhao, Shuo Shi, Jingjing Li, Xiao‐Dan Ji and Yuezhen Deng and has published in prestigious journals such as Nature Communications, Cancer Research and Biological Psychiatry.

In The Last Decade

Junfeng Xu

29 papers receiving 562 citations

Peers

Junfeng Xu

CMN

ONCOL

Annick Fraîchard France

Ling Zhong China

Roey Hadad United States

Maohong Cao China

Lucie Janečková Czechia

China N. Byrns United States

Andrea Ahles Germany

Jee-Yin Ahn South Korea

Jianfeng Liang China

Annick Fraîchard France

Junfeng Xu

393 ×1.1

94 ×0.6

70 ×0.6

CMN

31 ×0.4

ONCOL

107 ×1.6

Citations per year, relative to Junfeng Xu Junfeng Xu (= 1×) peers Annick Fraîchard

Countries citing papers authored by Junfeng Xu

Since Specialization

Citations

This map shows the geographic impact of Junfeng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junfeng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junfeng Xu more than expected).

Fields of papers citing papers by Junfeng Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junfeng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junfeng Xu. The network helps show where Junfeng Xu may publish in the future.

Co-authorship network of co-authors of Junfeng Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Junfeng Xu. A scholar is included among the top collaborators of Junfeng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junfeng Xu. Junfeng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Qin, Wenyan, Jianqiang Du, Feng Wang, & Junfeng Xu. (2025). Gastrodin: a potential natural product for the prevention and treatment of cerebral ischemia-reperfusion injury. Frontiers in Pharmacology. 16. 1554170–1554170. 1 indexed citations

Zeng, Ye, et al.. (2024). Comparison among different preclinical models derived from the same patient with a non-functional pancreatic neuroendocrine tumor. Human Cell. 37(5). 1522–1534. 1 indexed citations

Xu, Junfeng, Zheng Li, Qifeng Zhuo, et al.. (2022). Pevonedistat Suppresses Pancreatic Cancer Growth via Inactivation of the Neddylation Pathway. Frontiers in Oncology. 12. 822039–822039. 7 indexed citations

Zhang, Wenjuan, Lihui Li, Lili Cai, et al.. (2021). Tumor-associated antigen Prame targets tumor suppressor p14/ARF for degradation as the receptor protein of CRL2Prame complex. Cell Death and Differentiation. 28(6). 1926–1940. 18 indexed citations

Zhāng, Peng, et al.. (2021). Effect of acupuncture on sleep quality and neurological function in stroke patients with sleep apnea syndrome.. American Journal of Translational Research. 13(5). 5635–5640. 1 indexed citations

Zhang, Kun, et al.. (2020). The Role of Long Non-Coding RNAs in Thyroid Cancer. Frontiers in Oncology. 10. 941–941. 26 indexed citations

Xu, Junfeng, Da‐Tian Bau, Yifan Xu, et al.. (2020). Leukocyte telomere length is associated with aggressive prostate cancer in localized prostate cancer patients. EBioMedicine. 52. 102616–102616. 15 indexed citations

Tsai, Chia-Wen, Wen-Shin Chang, Junfeng Xu, et al.. (2020). Leukocyte telomere length is associated with aggressive prostate cancer in localized African American prostate cancer patients. Carcinogenesis. 41(9). 1213–1218. 9 indexed citations

Meng, Chen, et al.. (2020). Leukocyte Telomere Length and Bladder Cancer Risk: A Large Case–Control Study and Mendelian Randomization Analysis. Cancer Epidemiology Biomarkers & Prevention. 30(1). 203–209. 9 indexed citations

10.

Zhou, Hai-Yun, Jin‐Gang He, Zhuang‐Li Hu, et al.. (2019). A-Kinase Anchoring Protein 150 and Protein Kinase A Complex in the Basolateral Amygdala Contributes to Depressive-like Behaviors Induced by Chronic Restraint Stress. Biological Psychiatry. 86(2). 131–142. 53 indexed citations

11.

Xu, Junfeng, Chia-Wen Tsai, Wen-Shin Chang, et al.. (2019). Methylation of global DNA repeat LINE-1 and subtelomeric DNA repeats D4Z4 in leukocytes is associated with biochemical recurrence in African American prostate cancer patients. Carcinogenesis. 40(9). 1055–1060. 4 indexed citations

12.

Zhang, Ruonan, Junfeng Xu, Hui‐Yu Yi, et al.. (2018). An ML protein from the silkworm Bombyx mori may function as a key accessory protein for lipopolysaccharide signaling. Developmental & Comparative Immunology. 88. 94–103. 14 indexed citations

13.

Han, Yuyan, Junfeng Xu, Jeri Kim, Xifeng Wu, & Jian Gu. (2017). Methylation of subtelomeric repeat D4Z4 in peripheral blood leukocytes is associated with biochemical recurrence in localized prostate cancer patients. Carcinogenesis. 38(8). 821–826. 7 indexed citations

14.

Xu, Junfeng, et al.. (2016). Regulation of Oral Squamous Cell Carcinoma Proliferation Through Crosstalk Between SMAD7 and CYLD. Cellular Physiology and Biochemistry. 38(3). 1209–1217. 14 indexed citations

15.

Hu, Jun, et al.. (2016). HPV 16 E7 inhibits OSCC cell proliferation, invasion, and metastasis by upregulating the expression of miR-20a. Tumor Biology. 37(7). 9433–9440. 21 indexed citations

16.

Hu, Jun, et al.. (2016). MiR-497 enhances metastasis of oral squamous cell carcinoma through SMAD7 suppression.. PubMed. 8(7). 3023–31. 23 indexed citations

17.

Xu, Junfeng, Lihui Li, Guangyang Yu, et al.. (2014). The Neddylation-Cullin 2-RBX1 E3 Ligase Axis Targets Tumor Suppressor RhoB for Degradation in Liver Cancer. Molecular & Cellular Proteomics. 14(3). 499–509. 46 indexed citations

18.

Guo, Li, Xiao‐Dan Ji, Hong Gao, et al.. (2012). EphB3 suppresses non-small-cell lung cancer metastasis via a PP2A/RACK1/Akt signalling complex. Nature Communications. 3(1). 667–667. 101 indexed citations

19.

Ji, Xiao‐Dan, Li Guo, Yuxiong Feng, et al.. (2011). EphB3 Is Overexpressed in Non–Small-Cell Lung Cancer and Promotes Tumor Metastasis by Enhancing Cell Survival and Migration. Cancer Research. 71(3). 1156–1166. 87 indexed citations

20.

Shi, Lijun, Zhengping Zhang, Junfeng Xu, et al.. (2008). Heat shock protein 90 (Hsp90) regulates the stability of transforming growth factor β-activated kinase 1 (TAK1) in interleukin-1β-induced cell signaling. Molecular Immunology. 46(4). 541–550. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact